Research Overview
Origin and discovery
MOTS-c was identified by scanning the mitochondrial genome for short open reading frames capable of producing bioactive peptides. The resulting 16-residue product is translated from the 12S rRNA region and has been detected in plasma and multiple tissues, which is why it is often described in the literature as a mitochondrial signal acting on the nucleus — a form of retrograde communication.
Metabolic signaling
Most published work examines the peptide in the context of energy sensing:
- Reported activation of the AMPK pathway in cultured cells and rodent skeletal muscle
- Effects on glucose uptake and insulin sensitivity described in diet-induced obesity models
- Changes in fatty-acid oxidation markers reported in isolated muscle preparations
Aging and exercise models
Genetic variation
A mitochondrial single-nucleotide variant (m.1382A>C) changes one residue of the peptide and is enriched in certain Northeast Asian populations. Association studies of this variant with longevity and metabolic phenotypes are ongoing and remain an active question rather than a settled finding.
Analytical notes
The sequence contains two methionine residues and a tryptophan, so oxidation and light exposure are relevant stability considerations. Researchers commonly verify integrity by LC-MS after reconstitution when a preparation is stored for an extended period.